Avecho Biotechnology Ltd (Avecho) is based in Melbourne, Australia, and is listed on the Australian Securities Exchange - ASX:AVE. Avecho develops and commercialises innovative human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM®). TPM® is derived from Vitamin E using proprietary and patented processes, and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Avecho is actively developing a number of products with its unique TPM® technology, independently and with strategic partners. For more information, please visit avecho.com.au.
View Top Employees from Avecho Biotechnology LimitedWebsite | http://www.avecho.com.au |
Revenue | $1 million |
Employees | 14 (0 on RocketReach) |
Address | 2a Westall Rd, Clayton, Victoria 3168, AU |
Phone | +61 3 9002 5000 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Avecho Biotechnology Limited employee's phone or email?
The Avecho Biotechnology Limited annual revenue was $1 million in 2024.
Avecho Biotechnology Limited is based in Clayton, Victoria.
The NAICS codes for Avecho Biotechnology Limited are [325, 32, 3254, 32541].
The SIC codes for Avecho Biotechnology Limited are [283, 28].